Literature DB >> 20842689

Familial aggregation of Parkinson's disease in a multiethnic community-based case-control study.

Michael Y Shino1, Valerie McGuire, Stephen K Van Den Eeden, Caroline M Tanner, Rita Popat, Amethyst Leimpeter, Allan L Bernstein, Lorene M Nelson.   

Abstract

To assess the familial aggregation of Parkinson's disease (PD), we compared the cumulative incidence of PD among first-degree relatives of PD cases and controls. We identified newly diagnosed patients with PD (n = 573) during 1994 to 1995 within Kaiser Permanente Medical Care Program of Northern California and recruited 496 cases (87%) for the case-control study. Of 720 eligible controls matched by birth year and sex to cases, 541 (75%) agreed to participate. Information on family history of PD and other neurodegenerative diseases was obtained by in-person structured interview. We used the reconstructed cohort approach that provides a better estimate of the risk. The cumulative incidence of PD was significantly higher among relatives of PD patients compared with relatives of controls (2.0 vs. 0.7%; relative risk (RR) = 3.4, 95% confidence interval (CI) 1.9-5.9; P = 0.0001). The degree of familial aggregation was higher among first-degree relatives of Hispanic PD cases compared with Hispanic controls (3.7% vs. 0.4%; RR = 8.5, 95% CI 1.0-68.9) than it was among non-Hispanic Caucasian cases and controls (2.0% vs. 0.8%; RR = 2.7, 95% CI 1.5-5.1; P = 0.02). The familial aggregation of PD was stronger among the siblings of PD cases (RR = 5.4, 95% CI 1.8-16.0) than among parents (RR = 2.7, 95% CI 1.3-5.2). The incidence and familial aggregation of PD is highest among Hispanics, warranting further studies of genetic and environmental risk factors in the Hispanic population.
© 2010 Movement Disorder Society.

Entities:  

Mesh:

Year:  2010        PMID: 20842689      PMCID: PMC2978761          DOI: 10.1002/mds.23361

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  45 in total

1.  Genetics, drugs and environmental factors in Parkinson's disease. A case-control study.

Authors:  A L Werneck; H Alvarenga
Journal:  Arq Neuropsiquiatr       Date:  1999-06       Impact factor: 1.420

2.  Validity of family history data on PD: evidence for a family information bias.

Authors:  A Elbaz; S K McDonnell; D M Maraganore; K J Strain; D J Schaid; J H Bower; J E Ahlskog; W A Rocca
Journal:  Neurology       Date:  2003-07-08       Impact factor: 9.910

3.  "Familial Parkinson's disease"--a case-control study of families.

Authors:  R J Uitti; H Shinotoh; M Hayward; M Schulzer; E Mak; D B Calne
Journal:  Can J Neurol Sci       Date:  1997-05       Impact factor: 2.104

4.  Family history of tremor in Parkinson's disease compared with those of controls and patients with idiopathic dystonia.

Authors:  A E Lang; C Kierans; R D Blair
Journal:  Adv Neurol       Date:  1987

5.  Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study.

Authors:  C A Taylor; M H Saint-Hilaire; L A Cupples; C A Thomas; A E Burchard; R G Feldman; R H Myers
Journal:  Am J Med Genet       Date:  1999-12-15

6.  Risk factors of Parkinson's disease in Indian patients.

Authors:  M Behari; A K Srivastava; R R Das; R M Pandey
Journal:  J Neurol Sci       Date:  2001-09-15       Impact factor: 3.181

7.  Risk of Alzheimer's disease in relatives of Parkinson's disease patients with and without dementia.

Authors:  K Marder; M X Tang; B Alfaro; H Mejia; L Cote; E Louis; Y Stern; R Mayeux
Journal:  Neurology       Date:  1999-03-10       Impact factor: 9.910

8.  A family history of Parkinson's disease and its effect on other PD risk factors.

Authors:  B A Rybicki; C C Johnson; E L Peterson; G X Kortsha; J M Gorell
Journal:  Neuroepidemiology       Date:  1999       Impact factor: 3.282

9.  Familial Parkinson's disease: a community-based study.

Authors:  M Kurz; G Alves; D Aarsland; J P Larsen
Journal:  Eur J Neurol       Date:  2003-03       Impact factor: 6.089

10.  Risk of action tremor in relatives of tremor-dominant and postural instability gait disorder PD.

Authors:  E D Louis; G Levy; H Mejia-Santana; L Cote; H Andrews; J Harris; C Waters; B Ford; S Frucht; S Fahn; R Ottman; K Marder
Journal:  Neurology       Date:  2003-10-14       Impact factor: 9.910

View more
  7 in total

1.  LRRK2 G2019S mutations may be increased in Puerto Ricans.

Authors:  Rachel Saunders-Pullman; Jose Cabassa; Marta San Luciano; Kaili Stanley; Deborah Raymond; Laurie J Ozelius; Susan B Bressman
Journal:  Mov Disord       Date:  2011-03-29       Impact factor: 10.338

2.  Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease.

Authors:  Chuong B Do; Joyce Y Tung; Elizabeth Dorfman; Amy K Kiefer; Emily M Drabant; Uta Francke; Joanna L Mountain; Samuel M Goldman; Caroline M Tanner; J William Langston; Anne Wojcicki; Nicholas Eriksson
Journal:  PLoS Genet       Date:  2011-06-23       Impact factor: 5.917

Review 3.  Association between Parkinson's Disease and Cigarette Smoking, Rural Living, Well-Water Consumption, Farming and Pesticide Use: Systematic Review and Meta-Analysis.

Authors:  Charles B Breckenridge; Colin Berry; Ellen T Chang; Robert L Sielken; Jack S Mandel
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

4.  Familial aggregation of Parkinson's disease and coaggregation with neuropsychiatric diseases: a population-based cohort study.

Authors:  Fu-Chao Liu; Huan-Tang Lin; Chang-Fu Kuo; Mei-Yun Hsieh; Lai-Chu See; Huang-Ping Yu
Journal:  Clin Epidemiol       Date:  2018-05-30       Impact factor: 4.790

Review 5.  Genetic predispositions of Parkinson's disease revealed in patient-derived brain cells.

Authors:  Jenne Tran; Helena Anastacio; Cedric Bardy
Journal:  NPJ Parkinsons Dis       Date:  2020-04-24

6.  Characterizing the Genetic Architecture of Parkinson's Disease in Latinos.

Authors:  Douglas P Loesch; Andrea R V R Horimoto; Karl Heilbron; Elif I Sarihan; Miguel Inca-Martinez; Emily Mason; Mario Cornejo-Olivas; Luis Torres; Pilar Mazzetti; Carlos Cosentino; Elison Sarapura-Castro; Andrea Rivera-Valdivia; Angel C Medina; Elena Dieguez; Victor Raggio; Andres Lescano; Vitor Tumas; Vanderci Borges; Henrique B Ferraz; Carlos R Rieder; Artur Schumacher-Schuh; Bruno L Santos-Lobato; Carlos Velez-Pardo; Marlene Jimenez-Del-Rio; Francisco Lopera; Sonia Moreno; Pedro Chana-Cuevas; William Fernandez; Gonzalo Arboleda; Humberto Arboleda; Carlos E Arboleda-Bustos; Dora Yearout; Cyrus P Zabetian; Paul Cannon; Timothy A Thornton; Timothy D O'Connor; Ignacio F Mata
Journal:  Ann Neurol       Date:  2021-07-22       Impact factor: 11.274

7.  Impaired mitochondrial-endoplasmic reticulum interaction and mitophagy in Miro1-mutant neurons in Parkinson's disease.

Authors:  Clara Berenguer-Escuder; Dajana Grossmann; Paul Antony; Giuseppe Arena; Kobi Wasner; François Massart; Javier Jarazo; Jonas Walter; Jens C Schwamborn; Anne Grünewald; Rejko Krüger
Journal:  Hum Mol Genet       Date:  2020-05-28       Impact factor: 6.150

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.